India to Brazil: Fluticasone Export Trade Route
India has recorded 42 verified shipments of Fluticasone exported to Brazil, representing a combined trade value of $5.3M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $125.6K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 100% of total export value with 36 shipments worth $5.3M USD. On the buying side, MYLAN BRASIL DISTRIBUIDORA DE MEDIC is the largest importer in Brazil with $1.9M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Fluticasone corridor is one of India's established pharmaceutical export routes, with 42 shipments documented worth a combined $5.3M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's fluticasone manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $125.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 32.0%, placing it at rank #5 among India's top fluticasone export destinations globally.
On the import side, key buyers of Indian fluticasone in Brazil include MYLAN BRASIL DISTRIBUIDORA DE MEDIC, MYLAN BRASIL DISTRIBUIDORA DE MEDI, VIATRIS BRASIL IMPORTADORA E DISTRI and 4 others. MYLAN BRASIL DISTRIBUIDORA DE MEDIC is the single largest importer with 15 shipments valued at $1.9M USD.
